SIRT1 and hepatocellular carcinoma: Moreover, as for the other five studies, high SIRT1 expression was also associated with poor HCC prognosis (HR=1.90, 95%CI: 1.40-2.57, P<0.0001); no significant difference between subgroups was found (P=0.73).